No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BKD250117P6000
- 1.04
- +0.39+60.00%
15min DelayTrading Dec 23 11:22 ET
1.04High1.04Low
1.04Open0.65Pre Close5 Volume220 Open Interest6.00Strike Price520.00Turnover51.38%IV1.20%PremiumJan 17, 2025Expiry Date0.98Intrinsic Value100Multiplier25DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.9010Delta0.2960Gamma5.02Leverage Ratio-0.0019Theta-0.0022Rho-4.52Eff Leverage0.0023Vega
Intraday
- 5D
- Daily
News
Jefferies Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $8
Macquarie Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Announces Target Price $8
RBC Capital Maintains Brookdale Senior Living(BKD.US) With Buy Rating, Maintains Target Price $8
Analysts' Top Healthcare Picks: Brookdale Senior Living (BKD), Santhera Pharmaceuticals Holding (SPHDF)
Macquarie Maintains Outperform on Brookdale Senior Living, Maintains $8 Price Target
RBC Capital Reiterates Outperform on Brookdale Senior Living, Maintains $8 Price Target